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Background
Chemokines and their receptors play an important in
the late inflammatory stage occurring in asthma.
Objective
We aimed to investigate polymorphisms of MCP-1
(CCL2), CCR2 and CCR5 which can modify qualitatively
and/or quantitatively their production and thus influence
both susceptibility to asthma and its clinical and biological
features.
Patients and methods
MCP-1 (A/G -2518), CCR2 (+/64I), CCR5 (G/A -59029)
and CCR5 (Δ32) polymorphisms were detected by PCR in
107 Tunisian patients with asthma and 169 healthy
controls.
Results
We found no significant association between any of the
four investigated polymorphisms and asthma. Nevertheless
the haplotype MCP1*AG/CCR2*+/+ was significantly less
frequent in patients (20,5%) than in controls (32,5%)
p=0,03 OR=0,54 95% CI: 0,29-0,98. While no difference
observed in CCR2/CCR5 haplotypes between patients and
controls.
Analysis of polymorpohisms with clinical and biological
features showed a non significant decrease of the fre-
quency of MCP-1*G and CCR2*64I alleles in patients with
severe disease, moreover the concomitant presence of
MCP-1*G/CCR2*64I alleles was less frequent in severe
forms (4,34%) than in other patients (12%) but the differ-
ence was no longer significant p=0,27. No associations
were observed between the four polymorphisms and the
presence of atopic rhinitis or atopic conjunctivitis and an
elevated rate of serum IgE over 200 UI/ml.
Conclusion
Polymorphisms of MCP-1 and its receptor CCR2 seem
to be involved in disease-susceptibility to asthma in
Tunisian; nevertheless they could be protective against
its severe forms.
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